Search Results

There are 25322 results for: content related to: Brain energy metabolism is increased by chronic administration of bupropion

  1. You have free access to this content
    Antidepressants for smoking cessation

    Intervention Review

    The Cochrane Library

    John R Hughes, Lindsay F Stead, Jamie Hartmann-Boyce, Kate Cahill and Tim Lancaster

    Published Online : 8 JAN 2014, DOI: 10.1002/14651858.CD000031.pub4

  2. You have free access to this content
    Review of the Pharmacology and Clinical Profile of Bupropion, an Antidepressant and Tobacco Use Cessation Agent

    CNS Drug Reviews

    Volume 12, Issue 3-4, Fall/Winter 2006, Pages: 178–207, Linda P. Dwoskin, Anthony S. Rauhut, Kelley A. King-Pospisil and Michael T. Bardo

    Version of Record online : 11 JAN 2007, DOI: 10.1111/j.1527-3458.2006.00178.x

  3. How does bupropion work as a smoking cessation aid?

    Addiction Biology

    Volume 10, Issue 3, September 2005, Pages: 219–231, Charlotte Warner and Mohammed Shoaib

    Version of Record online : 9 JUN 2006, DOI: 10.1080/13556210500222670

  4. Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell

    European Journal of Neuroscience

    Volume 25, Issue 10, May 2007, Pages: 3099–3108, Neil E. Paterson, David J. Balfour and Athina Markou

    Version of Record online : 6 JUN 2007, DOI: 10.1111/j.1460-9568.2007.05546.x

  5. Stereoselective Bupropion Hydroxylation as an In Vivo Phenotypic Probe for Cytochrome P4502B6 (CYP2B6) Activity

    The Journal of Clinical Pharmacology

    Volume 48, Issue 4, April 2008, Pages: 464–474, Evan D. Kharasch, Darain Mitchell and Rebecka Coles

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008314254

  6. Evaluation of Bupropion Hydrochloride: The First of a New Class of Atypical Antidepressants

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 4, Issue 1, January-February 1984, Pages: 20–32, Sheldon H. Preskorn and Sieglinde C. Othmer

    Version of Record online : 24 JAN 2012, DOI: 10.1002/j.1875-9114.1984.tb03306.x

  7. Review of bupropion for smoking cessation

    Drug and Alcohol Review

    Volume 22, Issue 2, June 2003, Pages: 203–220, ROBYN RICHMOND and NICHOLAS ZWAR

    Version of Record online : 29 MAY 2009, DOI: 10.1080/09595230100100642

  8. Ritonavir Has Minimal Impact on the Pharmacokinetic Disposition of a Single Dose of Bupropion Administered to Human Volunteers

    The Journal of Clinical Pharmacology

    Volume 46, Issue 5, May 2006, Pages: 567–576, Dr Leah M. Hesse, Dr David J. Greenblatt, Dr Lisa L. von Moltke and Dr Michael H. Court

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270006286981

  9. QRS widening and QT prolongation under bupropion: a unique cardiac electrophysiological profile

    Fundamental & Clinical Pharmacology

    Volume 26, Issue 5, October 2012, Pages: 599–608, Bertrand Caillier, Sylvie Pilote, Annie Castonguay, Dany Patoine, Verlaine Ménard-Desrosiers, Patrick Vigneault, Raymond Hreiche, Jacques Turgeon, Pascal Daleau, Yves De Koninck, Chantale Simard and Benoit Drolet

    Version of Record online : 30 MAY 2011, DOI: 10.1111/j.1472-8206.2011.00953.x

  10. Bupropion treatment increases epididymal contractility and impairs sperm quality with no effects on the epididymal sperm transit time of male rats

    Journal of Applied Toxicology

    Volume 35, Issue 9, September 2015, Pages: 1007–1016, Marilia Martins Cavariani, Luiz Ricardo de Almeida Kiguti, Josiane de Lima Rosa, Gabriel Adan de Araújo Leite, Patrícia Villela e Silva, André Sampaio Pupo and Wilma De Grava Kempinas

    Version of Record online : 2 FEB 2015, DOI: 10.1002/jat.3089

  11. Dose-Related Reduction in Bupropion Plasma Concentrations by Ritonavir

    The Journal of Clinical Pharmacology

    Volume 50, Issue 10, October 2010, Pages: 1180–1187, Dr Joohyun Park, Ms Marika Vousden, Ms Claire Brittain, Dr Donavon J. McConn, Ms Laura Iavarone, Dr John Ascher, Dr Suzanne M. Sutherland and Dr Keith T. Muir

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009359524

  12. Single-dose pharmacokinetics of bupropion hydrobromide and metabolites in healthy adolescent and adult subjects

    Clinical Pharmacology in Drug Development

    Volume 4, Issue 5, September/October 2015, Pages: 346–353, D. Alexander Oh and Christopher S. Crean

    Version of Record online : 20 JUL 2015, DOI: 10.1002/cpdd.195

  13. You have free access to this content
    Pharmacological interventions for smoking cessation: an overview and network meta-analysis

    Overview of Reviews

    The Cochrane Library

    Kate Cahill, Sarah Stevens, Rafael Perera and Tim Lancaster

    Published Online : 31 MAY 2013, DOI: 10.1002/14651858.CD009329.pub2

  14. Randomized, placebo-controlled trial of bupropion in methamphetamine-dependent participants with less than daily methamphetamine use

    Addiction

    Volume 109, Issue 11, November 2014, Pages: 1878–1886, Keith G. Heinzerling, Aimee-Noelle Swanson, Timothy M. Hall, Yi Yi, Yingnian Wu and Steven J. Shoptaw

    Version of Record online : 5 AUG 2014, DOI: 10.1111/add.12636

  15. Single-Dose Pharmacokinetics of Bupropion in Adolescents: Effects of Smoking Status and Gender

    The Journal of Clinical Pharmacology

    Volume 41, Issue 7, July 2001, Pages: 770–778, Dr. John J. Stewart, Dr. Hans J. Berkel, Dr. Roy C. Parish, Dr. M. Renee Simar, Mr. Azeem Syed, Dr. Joseph A. Bocchini Jr., Dr. John T. Wilson and Dr. Joseph E. Manno

    Version of Record online : 8 MAR 2013, DOI: 10.1177/00912700122010564

  16. Characterization of the effects of bupropion on the reinforcing properties of nicotine and food in rats

    Synapse

    Volume 50, Issue 1, October 2003, Pages: 20–28, Adrie W. Bruijnzeel and Athina Markou

    Version of Record online : 1 JUL 2003, DOI: 10.1002/syn.10242

  17. Monoaminergic-based Pharmacotherapy for Depression

    Biology of Depression: From Novel Insights to Therapeutic Strategies

    George I. Papakostas, Maurizio Fava, Pages: 87–209, 2008

    Published Online : 29 JAN 2008, DOI: 10.1002/9783527619672.ch6

  18. Pharmacokinetics of Single- and Multiple-Dose Bupropion in Elderly Patients with Depression

    The Journal of Clinical Pharmacology

    Volume 35, Issue 9, September 1995, Pages: 876–884, Dr. Robert A. Sweet, Dr. Bruce G. Pollock, Ms. Margaret Kirshner, Dr. Bruce Wright, Ms. Linda P. Altieri and Dr. C. Lindsay DeVane

    Version of Record online : 8 MAR 2013, DOI: 10.1002/j.1552-4604.1995.tb04132.x

  19. Influence of acute bupropion pre-treatment on the effects of intranasal cocaine

    Addiction

    Volume 107, Issue 6, June 2012, Pages: 1140–1147, William W. Stoops, Joshua A. Lile, Paul E. A. Glaser, Lon R. Hays and Craig R. Rush

    Version of Record online : 11 FEB 2012, DOI: 10.1111/j.1360-0443.2011.03766.x

  20. Some neurochemical properties of a new antidepressant, bupropion hydrochloride (Wellbutrin™)

    Drug Development Research

    Volume 1, Issue 1, 1981, Pages: 21–35, Dr. R. M. Ferris, H. L. White, B. R. Cooper, R. A. Maxwell, F. L. M. Tang, O. J. Beaman and A. Russell

    Version of Record online : 5 OCT 2004, DOI: 10.1002/ddr.430010103